» Articles » PMID: 39193076

Leaky Gut Syndrome: Myths and Management

Overview
Specialty Gastroenterology
Date 2024 Aug 28
PMID 39193076
Authors
Affiliations
Soon will be listed here.
Abstract

Leaky gut syndrome is a condition widely popularized in the lay literature, although it is not currently accepted as a formal medical diagnosis. Multiple gastrointestinal symptoms are ascribed to leaky gut syndrome, including diarrhea, bloating, distension, abdominal pain, and dyspeptic symptoms of early satiety, nausea, and postprandial fullness. The etiology and pathophysiology of leaky gut syndrome are multifactorial; a preceding gastrointestinal infection, inflammatory bowel disease, and certain medications may be relevant factors in some patients. The diagnosis of leaky gut syndrome is problematic. Although patients are frequently informed that the diagnosis can be readily made using results from blood work or stool studies, no validated test currently exists to make this diagnosis. Patients report a variety of myths about the etiology, diagnosis, and treatment of leaky gut syndrome, which can cause alarm and can frequently lead to expensive, unnecessary tests and unproven, sometimes dangerous treatments. This article reviews some of the most common myths about leaky gut syndrome and provides data from the scientific literature to correct these statements. Management strategies, based on data, are provided when available.

Citing Articles

Intestinal Barrier Impairment, Preservation, and Repair: An Update.

Matar A, Damianos J, Jencks K, Camilleri M Nutrients. 2024; 16(20).

PMID: 39458489 PMC: 11509958. DOI: 10.3390/nu16203494.

References
1.
Smecuol E, Bai J, Sugai E, Vazquez H, Niveloni S, Pedreira S . Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut. 2001; 49(5):650-5. PMC: 1728510. DOI: 10.1136/gut.49.5.650. View

2.
Groschwitz K, Hogan S . Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009; 124(1):3-20. PMC: 4266989. DOI: 10.1016/j.jaci.2009.05.038. View

3.
Fritscher-Ravens A, Schuppan D, Ellrichmann M, Schoch S, Rocken C, Brasch J . Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014; 147(5):1012-20.e4. DOI: 10.1053/j.gastro.2014.07.046. View

4.
Wild G, Waschke K, Bitton A, Thomson A . The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFalpha production and nuclear factor kappa B expression. Aliment Pharmacol Ther. 2003; 18(3):309-17. DOI: 10.1046/j.1365-2036.2003.01611.x. View

5.
Konturek P, Brzozowski T, Konturek S . Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2012; 62(6):591-9. View